albunorm20%, 200g/l, solution for infusion
Last Updated on eMC 14-Nov-2016 View document | Octapharma Limited Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 14-Nov-2016 and displayed until Current
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 19-Jun-2015 and displayed until 14-Nov-2016
Reasons for adding or updating:
- Change to section 2 - what you need to know - contraindications
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - how to report a side effect
- Correction of spelling/typing errors
Updated on 27-Feb-2013 and displayed until 19-Jun-2015
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 09-Jan-2012 and displayed until 27-Feb-2013
Reasons for adding or updating:
- Unknown
Updated on 13-Nov-2009 and displayed until 09-Jan-2012
Reasons for adding or updating:
- New PIL for new product
Octapharma Limited
The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB
+44 (0)161 837 3799
+44 (0)161 837 3770
0845 1300 522
+44 (0)161 837 3799
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue